These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7184379

  • 1. [Phase I study of KW2083 7-N-(p-hydroxyphenyl) mitomycin C].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1844-50. PubMed ID: 7184379
    [Abstract] [Full Text] [Related]

  • 2. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S, Nagata T, Yokoyama K, Chinen T, Kobayashi T, Yamazaki H, Kuraishi Y, Ichiba, Abe M, Isogai Y.
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Shibuya M, Shimabukuro Z.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):834-9. PubMed ID: 6882001
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H, Hoshi A.
    Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
    Nishi I, Yokoyama T, Nakao I, Harashima S, Ohashi Y, Kanko T, Saito T.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
    [Abstract] [Full Text] [Related]

  • 6. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
    Takahashi K, Yokoyama M, Takahashi H, Wakui A.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Phase I study of raltitrexed (ZD-1694)].
    Horikoshi N, Aiba K, Fukuoka M, Akazawa S, Sakata Y, Furuse K, Kanamaru R, Kudoh S, Konishi T, Kurihara M, Niitani H, Furue H, Tsukagoshi S, Taguchi T, Yoshida S, Ota K, Kotake T, Wakui A.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2075-84. PubMed ID: 9838910
    [Abstract] [Full Text] [Related]

  • 10. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K, Hirabayashi K, Terashima Y, Ozaki M, Yakushiji M, Hatae M, Kanazawa K.
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [Abstract] [Full Text] [Related]

  • 11. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K, Wakui A, Saito T, Tominaga T, Niitani H, Fujimoto T, Masaoka T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [Abstract] [Full Text] [Related]

  • 12. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
    Meguro S, Nagata T, Yokoyama K, Chinen T, Yamazaki H, Kobayashi T, Isogai Y, Ogawa M.
    Invest New Drugs; 1984 Nov; 2(4):381-5. PubMed ID: 6511242
    [Abstract] [Full Text] [Related]

  • 14. Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors.
    Madden T, Tran HT, Beck D, Huie R, Newman RA, Pusztai L, Wright JJ, Abbruzzese JL.
    Clin Cancer Res; 2000 Apr; 6(4):1293-301. PubMed ID: 10778954
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of oral mitomycin C.
    Crooke ST, Henderson M, Samson M, Baker LH.
    Cancer Treat Rep; 1976 Nov; 60(11):1633-6. PubMed ID: 1035507
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
    Hurwitz HI, Cohen RB, McGovren JP, Hirawat S, Petros WP, Natsumeda Y, Yoshinari T.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):139-47. PubMed ID: 16819636
    [Abstract] [Full Text] [Related]

  • 17. Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
    Chung-Faye G, Palmer D, Anderson D, Clark J, Downes M, Baddeley J, Hussain S, Murray PI, Searle P, Seymour L, Harris PA, Ferry D, Kerr DJ.
    Clin Cancer Res; 2001 Sep; 7(9):2662-8. PubMed ID: 11555577
    [Abstract] [Full Text] [Related]

  • 18. [Phase I study of bestrabucil (KM 2210)].
    Kamei H, Takenaka K, Goto T, Suga S, Fugiwara A, Nakao I, Agatsuma T, Fujita K, Isurugi K, Kubota T.
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2208-15. PubMed ID: 3755019
    [Abstract] [Full Text] [Related]

  • 19. Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
    Roh JK, Rha SY, Lee CI, Lee KH, Lee JJ, Shim HJ, Lee SD, Kim WB, Yang J, Kim SH, Lee MG.
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):312-9. PubMed ID: 9660038
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of pazopanib in patients with advanced cancer.
    Hurwitz HI, Dowlati A, Saini S, Savage S, Suttle AB, Gibson DM, Hodge JP, Merkle EM, Pandite L.
    Clin Cancer Res; 2009 Jun 15; 15(12):4220-7. PubMed ID: 19509175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.